Matthew Plunkett - Net Worth and Insider Trading
Matthew Plunkett Net Worth
The estimated net worth of Matthew Plunkett is at least $536,383 dollars as of 2024-09-20. Matthew Plunkett is the EVP, Chief Business Officer of CTI BioPharma Corp and owns about 59,008 shares of CTI BioPharma Corp (CTIC) stock worth over $536,383. Details can be seen in Matthew Plunkett's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Matthew Plunkett has not made any transactions after 2016-03-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Matthew Plunkett
Matthew Plunkett Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Matthew Plunkett owns 3 companies in total, including Nkarta Inc (NKTX) , CTI BioPharma Corp (CTIC) , and Imago BioSciences Inc (IMGO) .
Click here to see the complete history of Matthew Plunkett’s form 4 insider trades.
Insider Ownership Summary of Matthew Plunkett
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NKTX | Nkarta Inc | 2020-07-09 | Chief Financial Officer |
| CTIC | CTI BioPharma Corp | 2016-03-04 | EVP & Corporate Development |
| IMGO | Imago BioSciences Inc | 2021-07-15 | Chief Financial Officer |
Matthew Plunkett Latest Holdings Summary
Matthew Plunkett currently owns a total of 1 stock. Matthew Plunkett owns 59,008 shares of CTI BioPharma Corp (CTIC) as of March 4, 2016, with a value of $536,383.
Latest Holdings of Matthew Plunkett
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CTIC | CTI BioPharma Corp | 2016-03-04 | 59,008 | 9.09 | 536,383 |
Holding Weightings of Matthew Plunkett
Matthew Plunkett Form 4 Trading Tracker
According to the SEC Form 4 filings, Matthew Plunkett has made a total of 0 transactions in CTI BioPharma Corp (CTIC) over the past 5 years. The most-recent trade in CTI BioPharma Corp is the sale of 1,000 shares on March 4, 2016, which brought Matthew Plunkett around $5,900.
Insider Trading History of Matthew Plunkett
- 1
Matthew Plunkett Trading Performance
Matthew Plunkett Ownership Network
Matthew Plunkett Owned Company Details
What does Nkarta Inc do?
Who are the key executives at Nkarta Inc?
Matthew Plunkett is the Chief Financial Officer of Nkarta Inc. Other key executives at Nkarta Inc include Chief Legal Officer Alicia J. Hager , Chief Medical Officer David Shook , and Sr. VP & Technical Operations Ralph Brandenberger .
Nkarta Inc (NKTX) Insider Trades Summary
Over the past 18 months, Matthew Plunkett made no insider transaction in Nkarta Inc (NKTX). Other recent insider transactions involving Nkarta Inc (NKTX) include a net sale of 9,598 shares made by James Trager , a net sale of 9,378 shares made by Alicia J. Hager , and a net sale of 5,778 shares made by David Shook .
In summary, during the past 3 months, insiders sold 3,396 shares of Nkarta Inc (NKTX) in total and bought 0 shares, with a net sale of 3,396 shares. During the past 18 months, 41,413 shares of Nkarta Inc (NKTX) were sold and 5,000,000 shares were bought by its insiders, resulting in a net purchase of 4,958,587 shares.
Nkarta Inc (NKTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Nkarta Inc Insider Transactions
Matthew Plunkett Mailing Address
Above is the net worth, insider trading, and ownership report for Matthew Plunkett. You might contact Matthew Plunkett via mailing address: 3101 Western Avenue, Suite 600, Seattle Wa 98121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
